providence Biotechnology  banner
 
Home | About us | Products | Technology | Management | Contact us

Management Team

Providence Biotechnology Solutions has a capable and experienced management team.

Dr. Sacha D. Simon
Chairman, Chief Medical Officer and Founder

Dr. Simon founded Providence Biotechnology Solutions in 2007 and has been key in orchestrating growth by building critical relationships with researchers and vendors to assure the Providence Biotechnology Solutions’ continued viability.   Dr. Simon is currently a General Practitioner in the South Warwickshire region of the United Kingdom. Initially trained in orthopaedic surgery, he has extensive experience in dealing with patients with joint disorders in both hospital and primary care settings. He has previously worked as Medical Director for HOPE worldwide – Afghanistan.

Dr. Simon holds a BSc. Molecular Biochemistry and a MBBS from the University of London.  He is a member of the Royal College of Surgeons and the Royal College of General Practitioners.

 

Mr. James J. Hill
President and Chief Executive Officer

Mr. Hill joined Providence Biotechnology Solutions in 2007. Before joining Providence Biotechnology Solutions, Mr. Hill worked for Express Scripts, Inc. as Vice President, Pharmaceutical Trade Relations. Specific management accomplishments include management of three corporate divisions producing $10 billion in annual revenue.  

Mr. Hill has extensive contacts and established relationships with numerous CEOs and other high-level executives in the pharmaceutical industry. A registered pharmacist, he holds a BS in Pharmacy from the St. Louis College of Pharmacy and a MBA in finance from Saint Louis University. Mr. Hill sits on the boards of directors for the American Diabetes Association and the Asthma and Allergy Foundation of America.


Mr. James J. Tabor
Chief Financial Officer

Mr. Tabor is a certified public accountant and a certified financial planner.  For the past 18 years he has been managing partner of accounting firm Tabor & Guard, LLC. Prior to founding this firm, he spent six years at Price Waterhouse Coopers as a senior tax consultant. 

Mr. Tabor holds a BS in Accounting from Saint Louis University.

 

Mrs Onyema Bright
Non-Executive Director

Mrs. Bright is the former non-executive director for Sheffield Teaching Hospitals NHS Foundation Trust Board. The Trust is among the top four largest trusts in the UK, with a current budget of £(UK)500 million/PA and employs 12,000 staff. She has extensive experience in managing contracts within the NHS.

Advisory Board

The following individuals make up the Providence Biotechnology Solutions Advisory Board:

Michael A. Schultz, RPh, - Managing Partner, VCG&A, Inc.

Mr. Schultz has over 25 years of experience in the pharmaceutical industry.  Prior to founding VCG&A, a pharmaceutical consultancy, he held various senior level positions in sales, marketing and business development in several major pharmaceutical companies.  His firm has participated in the development and commercial launch of over 25 different pharmaceutical products and medical devices.

David P. Coffin-Beach, PhD - President and Chief Operating Officer, Synovics Pharmaceuticals, Inc.

Holding a PhD in pharmaceutical manufacturing, Dr. Beach has extensive experience in drug formulation, product development, FDA drug filings and pharmaceutical manufacturing.  Prior to joining Synovics, Dr Beach did pharmaceutical consulting and spent 11 years as President and Director of TorPharm, Inc., a division of Apotex, Inc. 

Faraneh Attarchi, PhD, RAC - Regulatory Director, Quintiles Transnational

Dr. Attarchi has 23 years of experience in the pharmaceutical industry (14 years of experience in solid formulation development and 9 years of regulatory experience as a certified regulatory affairs strategist).  She has had extensive interaction with the FDA and has conducted Pre-IND meetings with the FDA’s Division of Analgesics, Anesthetics and Rheumatology Products.   Dr Attarchi holds a BS degree in Pharmacy from Teheran University, a MS in Medicinal Chemistry from University of South Carolina, a her Ph.D. in pharmaceutics from University of Wisconsin in Madison, WI.

Timothy H Cooke FCA

Mr Cooke is a Finance Director with experience of being FD in businesses from $10 million to $1 billion turnover, with UK, American and Japanese ownership/culture. Since qualifying as a Chartered Accountant has worked for KPMG, GKN, Staveley Industries (Salter weighing scales), De La Rue (Crosfield Electronics-Hi-tech colour printing), Cadbury Schweppes (IT contracts) and Tyco Electronics UK Ltd.

 

 
   
  ©2007 Providence Biotechnology Solutions Ltd . All Rights Reserved
home about us products technology contacts
home about us products technology contacts